tiprankstipranks
Trending News
More News >
Lexston Life Sciences Corp. (TSE:LEXT)
:LEXT
Canadian Market

Lexston Life Sciences Corp. (LEXT) Financial Statements

Compare
5 Followers

Lexston Life Sciences Corp. Financial Overview

Lexston Life Sciences Corp.'s market cap is currently C$1.48M. The company's EPS TTM is C$; its P/E ratio is -0.42; Lexston Life Sciences Corp. is scheduled to report earnings on January 7, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 361.01KC$ 149.11K
Gross ProfitC$ 0.00C$ -26.39KC$ -29.80KC$ 241.49KC$ 60.10K
Operating IncomeC$ -1.35MC$ -674.72KC$ -871.53KC$ -2.00MC$ -491.09K
EBITDAC$ -1.54MC$ -648.32KC$ -841.73KC$ -2.29MC$ -479.82K
Net IncomeC$ -1.62MC$ -867.71KC$ -1.11MC$ -2.32MC$ -876.13K
Balance Sheet
Cash & Short-Term InvestmentsC$ 2.32KC$ 390.40KC$ 511.00KC$ 590.49KC$ 949.17K
Total AssetsC$ 279.49KC$ 750.95KC$ 814.30KC$ 952.80KC$ 1.10M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -2.32KC$ -390.40KC$ -511.00KC$ -590.49KC$ -949.17K
Total LiabilitiesC$ 208.82KC$ 39.87KC$ 11.21KC$ 79.09KC$ 38.81K
Stockholders' EquityC$ 70.67KC$ 711.08KC$ 803.10KC$ 873.71KC$ 1.06M
Cash Flow
Free Cash FlowC$ -1.19MC$ -723.16KC$ -987.74KC$ -1.40MC$ -608.63K
Operating Cash FlowC$ -1.19MC$ -523.18KC$ -987.74KC$ -1.40MC$ -483.16K
Investing Cash FlowC$ -10.00KC$ -199.99KC$ 0.00C$ -109.97KC$ 812.32K
Financing Cash FlowC$ 814.66KC$ 602.57KC$ 908.24KC$ 1.15MC$ 620.01K
Currency in CAD

Lexston Life Sciences Corp. Earnings and Revenue History

Lexston Life Sciences Corp. Debt to Assets

Lexston Life Sciences Corp. Cash Flow

Lexston Life Sciences Corp. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.